Dr. Carolyn Y. Muller, MD

Dr. Muller practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Muller's NPI, 1598772550, was assigned on August 2, 2006. Dr. Muller graduated from Perelman School of Med at the University of Pennsylvania in 1988. Dr. Muller holds New Mexico license MD2004-0730.

Dr. Muller's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Muller's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. Dr. Muller is also affiliated with CHRISTUS St. Vincent Regional Medical Center. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Muller to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Muller practices, 3 sites in all. Vendor and product names are available with a free account.

Gynecologic oncology is Dr. Muller's primary specialty in the NPI Registry, under taxonomy code 207VX0201X. Dr. Muller is licensed in New Mexico.

CMS data shows 448 Medicare services from Dr. Muller across 5 procedure codes in 2024, for 149 Medicare patients. Medicare paid $22,262 for them. Every service was in an office.

CMS counts 149 Medicare patients who saw Dr. Muller in 2024. The largest group is 65 to 74, with 79 patients. 59% of them have high cholesterol, and 55% have high blood pressure. 12% are also on Medicaid. Their average risk score is 1.30, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Muller's median patient age at 71, with 100% women.

In 2024, Dr. Muller wrote 49 Medicare Part D claims for 13 patients. 92% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $36 in total drug cost. In 2016, CMS named 12 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Muller for performance year 2024, reported as part of a group. Dr. Muller accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Removal of the uterus: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 31 papers to Dr. Muller, published from 2011 to 2024. 2015 was the busiest year, with 4. The most frequent topics are Ovarian Neoplasms, Antineoplastic Combined Chemotherapy Protocols and Carcinoma, Ovarian Epithelial. Dr. Muller has published most often in Gynecol Oncol. Dr. Muller's most frequent co-authors are Teresa L. Rutledge, MD, Carol Aghajanian, MD and David P. Bender, MD.

Dmand AI links Dr. Muller to 10 clinical trials, 5 of them phase 3 studies. 8 are still active or recruiting. Conditions studied include Fallopian Tube Diseases, Fallopian Tube Neoplasms and Carcinosarcoma. National Cancer Institute (NCI) sponsors the most, 8.

CMS Open Payments shows 19 general payments to Dr. Muller from 8 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 70% of the total. GlaxoSmithKline, LLC. paid the most, $4,154.

Dr. Muller graduated from Perelman School of Med at the University of Pennsylvania in 1988.